Publikationen in Zusammenarbeit mit Forschern von Università di Perugia (29)

2024

  1. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

  2. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

    Nature Communications, Vol. 15, Núm. 1

  3. Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network

    European Journal of Cancer, Vol. 196

2023

  1. Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies

    Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657

  2. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

    Journal of Clinical Oncology, Vol. 41, Núm. 2, pp. 212-221

  3. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    Annals of Oncology, Vol. 34, Núm. 5, pp. 452-467

2022

  1. Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

    European Journal of Haematology, Vol. 108, Núm. 1, pp. 73-83

  2. The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres

    European Journal of Cancer, Vol. 177, pp. 72-79

2021

  1. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  4. Survival and quality of life after early discharge in low-risk pulmonary embolism

    European Respiratory Journal, Vol. 57, Núm. 2

  5. Who Will Take Care of Me? The Future of Human Resources in Anaesthesiology, Critical Care, and Emergency Medicine in Europe

    Research Anthology on Cross-Industry Challenges of Industry 4.0 (IGI Global), pp. 752-766

2020

  1. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial

    European Heart Journal, Vol. 41, Núm. 4, pp. 509-518

  2. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

    The Lancet Haematology, Vol. 7, Núm. 10, pp. e746-e755

  3. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 8, pp. 1940-1951

  4. The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale

    Gerontology, Vol. 66, Núm. 5, pp. 447-459

2019

  1. Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): Single institution experience and systematic literature review

    Journal of Contemporary Brachytherapy, Vol. 11, Núm. 1, pp. 54-60

  2. Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

    NeuroImage: Clinical, Vol. 23

2018

  1. Ent cobra ontology: the covariates classification system proposed by the Head & Neck and Skin GEC-ESTRO Working Group for interdisciplinary standardized data collection in head and neck patient cohorts treated with interventional radiotherapy (brachytherapy)

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 3, pp. 260-266